Original articleThe RESTORE Study: Ranibizumab Monotherapy or Combined with Laser versus Laser Monotherapy for Diabetic Macular Edema
Cited by (0)
Appendix 4 contains a list of the primary investigators who participated in this study (available online at http://aaojournal.org).
The authors thank Aditi Gandhe (Novartis Healthcare Private Ltd., India) for her medical writing and editorial assistance and Shivani Mittra (Novartis Healthcare Private Ltd., India) for her contribution toward various drafts of this manuscript.
Manuscript no. 2010-1525.
Financial Disclosure(s): The authors have made the following disclosures:
P. Mitchell – Novartis – Consultant, Lecturer; Pfizer – Consultant, Lecturer; Allergan – Consultant; Solvay – Consultant; Bayer – Consultant.
F. Bandello – Novartis – Consultant, Lecturer; Allergan – Consultant, Lecturer; Thea – Consultant, Lecturer.
U. Schmidt-Erfurth – Alcon Laboratories, Inc. – Consultant, Lecturer; Bayer Healthcare – Consultant, Lecturer; Novartis – Consultant, Lecturer; Regeneron – Lecturer; Pfizer – Lecturer.
P. Massin – Novartis – Consultant, Lecturer; Allergan – Consultant, Lecturer; Fovea Pharmaceutical – Consultant; Sanofi Aventis – Consultant; Takeda – Consultant, Lecturer.
R.O. Schlingemann – Novartis – Consultant, Lecturer; Bayer Healthcare – Consultant.
F. Sutter – Novartis – Consultant.
G. Burian – Novartis Pharma – Employee.
O. Gerstner – Novartis Pharma – Employee.
A. Weichselberger – Novartis Pharma – Employee.
Sponsored by Novartis Pharma AG, Switzerland. The study is registered with www.clinicaltrial.gov under number NCT00687804.
- ⁎
Group members listed online in Appendix (available at http:///aaojournal.org)